Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Oxazole-based inducers of BDNF production and their use in diabetic neuropathy

July 2, 2003

Phase I results for NBI-42902

July 2, 2003

Aventis and Zealand sign licensing agreement for ZP-10

July 1, 2003

U.K. approval for Testim

July 1, 2003

Calyx patent covers new agents for diabetes, inflammation, etc.

July 1, 2003

Dr. Reddy's presents new PPARalpha agonists in recent patent

July 1, 2003

European Commission grants marketing authorization for Aldurazyme in Europe

June 30, 2003

Scientists at Fujisawa and Daiso present novel apo B secretion inhibitors

June 30, 2003

Y-700 found to inhibit uric acid formation in healthy adult volunteers

June 30, 2003

Genzyme exercises option to acquire 50% interest in DX-88 for HAE

June 27, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...